Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 12487
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
62361
IPIX Finra short sales for 2/19/20
(3)
STEEL PENNY
02/19/2020 11:38:40 PM
62360
Bezos and Gates have active philanthropic health
(1)
Commando911
02/19/2020 11:32:58 PM
62356
Coronas article attached with permission from
(9)
Mo
02/19/2020 1:25:47 PM
62350
Yesterday I made a post about one of the main
(14)
petemantx
02/19/2020 9:31:41 AM
62348
IPIX Finra short sales for 2/18/20
(3)
STEEL PENNY
02/19/2020 3:18:26 AM
62346
For some reason the link did not work?? It was
(2)
annakneemuss
02/18/2020 10:54:14 PM
62345
It seems that we have many newcomers lately.
(8)
scgmck1
02/18/2020 10:32:14 PM
62342
Combined with the safety profile, the potential
(2)
DoraBrown
02/18/2020 2:35:41 PM
62341
WilliamSC From the UC P1 PR. "For Brilacidin
(1)
bettingbig
02/18/2020 2:08:12 PM
62340
That just means that more of those Swamp rats
(4)
scgmck1
02/18/2020 1:34:17 PM
62339
Go Leo. I just wanted to say if BDD formulates
(2)
williamsc
02/18/2020 1:28:02 PM
62338
The science continues to steadily move forward.
(4)
AlanC
02/18/2020 1:24:22 PM
62337
The news is so good that LIEHUB has gone off
(2)
Fit007
02/18/2020 12:59:18 PM
62336
Thanks for the link to the lab, Drano. As I have
(4)
scgmck1
02/18/2020 12:48:06 PM
62335
DJIA: 29,183.81 -214.27 (-0.73%) | NASDAQ:
(2)
Fit007
02/18/2020 12:43:04 PM
62334
For newer members, Brilacidin was developed by
(16)
petemantx
02/18/2020 12:08:28 PM
62331
*Innovation Pharma Says Has Received Inquiries
(1)
Fit007
02/18/2020 11:48:33 AM
62330
This morning's Share Holder Alert was just
(6)
Mo
02/18/2020 11:33:44 AM
62329
As per the email: Brilacidin already has
(4)
Kelt
02/18/2020 11:27:11 AM
62328
Has B been tested in the lab for anti-viral
gchgch
02/18/2020 11:17:02 AM
62325
Could this get a Coronavirus rise like some of
(1)
Boneysteak
02/18/2020 10:59:28 AM
62324
From email received........... Defensins are
(1)
Waikikian
02/18/2020 10:55:29 AM
62323
Well,it looks like Brilicidin (and Kevetrin) are
(12)
Kelt
02/18/2020 10:51:34 AM
62322
Down with LieHub
CrazyCravings
02/18/2020 10:46:19 AM
62321
Pete did say he thought Novartis was a snake in
DoraBrown
02/18/2020 10:32:58 AM
62320
Volume 319.351 after 40 minutes.
(1)
Drano
02/18/2020 10:12:52 AM
62319
Surprise! Novartis and other companies guilty of
(1)
Drano
02/18/2020 10:08:05 AM
62318
Volume 248,975 after 15 minutes. Last 50k shares
Drano
02/18/2020 9:45:00 AM
62316
Defensins are conceptually ideal for defense
(5)
Shry
02/18/2020 9:07:21 AM
62314
It's hard to tell. Obviously any of those names
(1)
DoraBrown
02/17/2020 10:08:00 AM
62313
I know they had scheduled meetings at JP Morgan
bettingbig
02/17/2020 10:04:14 AM
62312
Depending on the rest of the terms that might be
(1)
DoraBrown
02/17/2020 9:55:35 AM
62310
I viewed an interesting post that went
Fit007
02/17/2020 9:39:50 AM
62309
I doubt IPIX would consider any offer for 25m.
(2)
Jimmyboy
02/17/2020 8:17:24 AM
62308
Dora Why do you think Leo held meetings with
(3)
bettingbig
02/17/2020 7:57:01 AM
62305
There are a ton of BPs who will take a shot on
(3)
DoraBrown
02/16/2020 10:52:15 PM
62303
https://infectionsinsurgery.org/judicious-use-of-
(2)
annakneemuss
02/16/2020 8:26:55 PM
62302
This is the link to the Global sight of judicious
(4)
annakneemuss
02/16/2020 8:21:28 PM
62301
Agreed petemantx
(1)
Commando911
02/16/2020 7:27:53 PM
62300
Those claiming $10 for Brilacidin is a good deal
(13)
petemantx
02/16/2020 5:17:58 PM
62299
IMO With UC alone being a $7B market as of 2017
(1)
bettingbig
02/16/2020 5:09:44 PM
62298
You can forget that RS crap. That'll not happen
(4)
scgmck1
02/16/2020 5:04:58 PM
62297
Trying to interpret your statement: Sell
(1)
djs7
02/16/2020 2:22:16 PM
62296
There is a price for every thing. $2 billion for
(3)
DoraBrown
02/16/2020 1:54:16 PM
62295
IMO NO way he sells all of B. Way to many
(1)
bettingbig
02/16/2020 1:41:09 PM
62294
Thanks for reminding me of that PR ...it sure
(2)
Chemdeps
02/16/2020 1:20:21 PM
62293
I'm liking this from the 12/26/2019 PR. The
(10)
bettingbig
02/16/2020 11:05:49 AM
62292
"Having no systemic absorption will mean the
(5)
williamsc
02/15/2020 9:23:54 PM
62290
Yes. The doses from the UP test give a baseline
(6)
Drano
02/15/2020 3:40:56 PM
62288
Remember UPS is the Mildest form of UC. This is
(9)
bettingbig
02/15/2020 1:52:44 PM
Newer
Older
Recent Articles
Understanding the TikTok Deal: Implications for ByteDance's Future
C3.ai Faces Class Action Lawsuit: Key Details for Investors
Class Action Notice for KinderCare Investors Amid Concerns
Investors Alert: Participate in Class Action Against SOC Now
Flywire Corporation Lawsuit Highlights Investor Rights Overview
ACI Learning Partners with OMREN for Enhanced Cybersecurity Skills
China World Summit Wing’s Vertical Run: A Community Celebration
Celebrating the Legacy of the Kashi Fair: A Cultural Journey
L Catterton's Investment Fuels Seki Furniture's Growth
Unveiling New Partnerships at the 2025 Media Cooperation Forum
Cathie Wood's Bold Investment Moves: Key Stock Adjustments
Snap Inc. Accused of Misleading Statements in Lawsuit
Wanda L. James Unveils Congressional Campaign for Change
Qlarant Joins Agile4Vets to Enhance Veteran Healthcare Services
Qlarant Joins Forces to Transform Veteran Healthcare Services
Sable Offshore faces investor lawsuit over production claims
Coty's Stock Troubles: A Deeper Look into Retail Challenges
AI Startup Born Secures $15 Million to Combat Loneliness
Elcogen Unveils Cutting-Edge Manufacturing Facility for Clean Energy
Trailblazer Merger Corporation I Reschedules Annual Meeting
Understanding the Fluor Corporation Class Action Lawsuit Details
Explore Artistic Possibilities with Wacom One 14 Pen Display
Ubiqconn and RuggON Present Innovative Solutions at TADTE
KT&G Showcases ESSE at Intertabac 2025 to Boost Global Reach
Investors Concerns Over Fly-E Group, Inc. Amid Class Action
Understanding Class Action Opportunities for Savara Investors
Diversified Energy's Secondary Offering: Key Insights Ahead
Cygnus Metals Boosts Resource Estimate in Copper-Gold Project
V.F. Corporation Class Action Lawsuit: Key Information for Investors
Diversified Energy's Recent Ordinary Shares Offering Explained
Transforming Client Care: Emily Mehr's Role at Sweet James
Beauty Power's Nail Care Set Wins Prestigious Beauty Award
Former CIA Officer Discusses AI Project Impact on America
Elliott Investment Management's Support for Workday's Future
The Journey of a $1000 Microsoft Investment Over 20 Years
Clorox Company Announces New Quarterly Dividend of $1.24
Savara Inc. Investors Get Opportunity for Class Action Suit
Investors Take Action in Lockheed Martin Securities Case
Investigation Launch by Rosen Law for Encompass Health Investors
Elliott Investment Management's Progressive Outlook on Workday
Landmark Study Highlights NobleStitch™ PFO Closure Benefits
Nxera Pharma Advances Immunotherapy Research in Cancer Clinical Trial
Western Forest Products Secures New US$30 Million Credit Facility
Western Forest Products Secures a New $30 Million Credit Facility
Discover the Growth Potential of Progressive Investments
Altimmune Investors Urged to Act Before Class Action Deadline
Revolutionizing Storytelling: Verily Storyworks Emerges
Breakthrough Results from ASC30 Study Unveiled at EASD Meeting
Navigating Opportunities in Recent Sable Offshore Corp. Lawsuit
Eisai's Etalanetug Tau Antibody Receives FDA Fast Track Status